Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Arthritis, Psoriatic; Arthritis, Juven...

Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Arthritis, Psoriatic;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid;Colitis, Ulcerative;Crohn Disease;Hidradenitis Suppurativa;Psoriasis;Spondylitis, Ankylosing;Uveitis Human medicines European public assessment report (EPAR): Hukyndra, adalimumab, Arthritis, Psoriatic;Arthritis, Juvenile Rheumatoid;Arthritis, Rheumatoid;Colitis, Ulcerative;Crohn Disease;Hidradenitis Suppurativa;Psoriasis;Spondylitis, Ankylosing;Uveitis, Date of authorisation: 15/11/2021, Revision: 1, Status: Authorised       Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched, , 25/01/2022 On 31 January 2022, the Clinical Trials Regulation (CTR) will come into application harmonising the submission, assessment and supervision processes for...       VGN-webinar: wat zijn mbo-certificaten en welke oplossingen bieden ze?

Actueel zorgnieuws in jouw mailbox ontvangen?

Direct het hele artikel lezen? Meld je aan voor de nieuwsbrief.